Neurostimulation Device for Treatment of Migraine Headache (NCT01630044) | Clinical Trial Compass
CompletedNot Applicable
Neurostimulation Device for Treatment of Migraine Headache
United States3 participantsStarted 2012-05
Plain-language summary
This is a single-site, prospective, non-randomized and open label study to investigate the feasibility of home-use CVS for the prevention of episodic migraine headache and specifically to better understand what type of waveform to apply.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* A history of at least four, and not more than fourteen total monthly headache days of which between four and nine were migraine headache days. (Note: Patients were permitted continued access to migraine abortive medications and were being treated at the Duke University headache clinic.)
* A history of some responsiveness (incomplete) to at least one and a maximum of two prophylactic pharmaceutical therapies (utilized concurrently);
* The investigator must have confidence in the patient's ability to reliably complete and return the Daily Headache Diary.
* Subject must be at least 18 years of age.
Exclusion Criteria:
* Individuals who were pregnant, who had a history of cardiovascular disease, who worked night shifts or who had vestibular migraine, menstrual migraine, post-traumatic migraine, a history of unstable mood disorder or unstable anxiety, moderate or greater hearing loss or a history of traumatic brain injury.
* A history within the last six months of tobacco use, narcotic or barbiturates use or experiencing one or more analgesic rebound headaches.